Table 3. Rate of AECOPD events before and after Ig treatment classified by stage of COPD based on GOLD criteria, presence or absence of radiographic bronchiectasis, or baseline IgG level.
Before (AECOPD events/patient-year) | After (AECOPD events/patient-year) | |
---|---|---|
Stage of COPD | ||
Moderate COPD (n = 7) | 5.14 ± 2.85 | 0.86 ± 1.13 |
Severe / very severe COPD | 4.14 ± 2.95 | 0.43 ± 0.5 |
Presence of bronchiectasis | ||
No bronchiectasis (n = 6) | 4.00 ± 2.83 | 0.83 ± 1.07 |
With bronchiectasis | 5.13 ± 2.93 | 0.50 ± 0.71 |
Baseline IgG level | ||
IgG ≥ 5.9 g/L (n = 7) | 4.29 ± 3.33 | 0.29 ± 0.45 |
IgG < 5.9 g/L | 5.00 ± 2.45 | 1.00 ± 1.07 |
IgG = 5.9 g/L is the median IgG in our case series.